Merck, a science and technology company, has entered into a definitive agreement to acquire HUB Organoids Holding B.V., a Netherlands-based pioneer in organoid technology. The acquisition aims to enhance Merck’s expertise in next-generation biology and drug discovery. Terms of the
Merck Life Science KGaA Contract Manufacturing & Development (CDMO) Profile Life Science Business of Merck KGaA Darmstadt Germany. Merck/MilliporeSigma supplies the global Life Science industry with solutions and services for research, biotechnology development & production, and pharmaceutical drug therapy development
“What we do in pharma is urgent—patients can’t wait for the products we’re here to produce” says Matthew Dodge, PhD, PMP, Associate Director, Project Management at Merck Ahead of CDMO Live, Matt explains how project management has a key role
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
